Details for New Drug Application (NDA): 017760
✉ Email this page to a colleague
NDA 017760 describes FML, which is a drug marketed by Allergan and Abbvie and is included in four NDAs. It is available from two suppliers. Additional details are available on the FML profile page.
The generic ingredient in FML is fluorometholone; sulfacetamide sodium. There are five drug master file entries for this compound. Additional details are available on the fluorometholone; sulfacetamide sodium profile page.
The generic ingredient in FML is fluorometholone; sulfacetamide sodium. There are five drug master file entries for this compound. Additional details are available on the fluorometholone; sulfacetamide sodium profile page.
Summary for 017760
| Tradename: | FML |
| Applicant: | Allergan |
| Ingredient: | fluorometholone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017760
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 0.1% | ||||
| Approval Date: | Sep 4, 1985 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
